Covaxin, Covishield granted regular market approval in India
National Herald
2022-01-31
Views 85
The Drugs Controller General of India (#DCGI) Thursday granted regular market approval for #COVID19Vaccines — #Covishield and #Covaxin — for use in the adult population subject to certain conditions. The approval was granted under the New Drugs and Clinical Trials Rules, 2019.
#CDSCO
#CDSCO
Report form
